Pfizer-BioNTech says its COVID vaccine 100% effective in teens Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer said on Wednesday that their COVID-19 vaccine was 100-percent efficient in children aged between 12 and 15. The BNT162b2 vaccine was “well tolerated” and elicited robust antibody responses that …
Read More »U.S. researchers investigating Pfizer-BioNTech vaccine allergic reactions
Washington, U.S. | Xinhua | Scientists have speculated that the compound polyethylene glycol, also known as PEG, could cause allergic reactions to the COVID-19 vaccine developed by U.S. company Pfizer and German company BioNTech, media reported. This comes after the U.S. Center for Disease Control and Prevention identified six reports of …
Read More »COVID-19: Pfizer, bioNTech vaccine approved for emergency use
Kampala, Uganda | THE INDEPENDENT | The US Food and Drug Administration has authorized the emergency use of Pfizer and BioNTech Covid-19 vaccines in the United States. The approval of two vaccines that were produced by US pharmaceutical companies follows data from an independent monitoring board showing that the drug that …
Read More »Bahrain approves new COVID-19 vaccine use
Manama, Bahrain | Xinhua | Bahrain’s health regulator on Friday announced the authorization of emergency use of the Pfizer/BioNTech COVID-19 vaccine. “Bahrain has approved the emergency use of Pfizer/BioNTech COVID-19 vaccine that will be used for high risk groups,” said the National Health Regulatory Authority (NHRA). It added that …
Read More »Pfizer and BioNTech say COVID-19 vaccine 95% effective
Mainz, Germany | THE INDEPENDENT | Drug companies Pfizer and BioNTech have conclude Phase 3 Study of their COVID-19 Vaccine candidate BNT162b2 , whose primary efficacy analysis demonstrates it to be 95% effective against COVID-19 beginning 28 days after the first dose. According to a statement, efficacy was consistent across …
Read More »BioNTech and Pfizer make COVID-19 vaccine breakthrough
Mainz, Germany | THE INDEPENDENT | German company BioNtech and Pfizer from the US have announced success in phase three study of an experimental vaccine to prevent COVID-19 infections. “Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine …
Read More »